GT Biopharma (GTBP) had the highest return between March 5, 2017 and March 25, 2017 by a US stock, returning 7,371,718.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | 3/5/2017 - 3/25/2017 | 7,371,718.18% |
OLB (OLB) | 3/5/2017 - 3/25/2017 | 200% |
Pulse Biosciences (PLSE) | 3/5/2017 - 3/25/2017 | 105.28% |
VerifyMe (VRME) | 3/5/2017 - 3/25/2017 | 100% |
Opus Genetics (IRD) | 3/5/2017 - 3/25/2017 | 80.8% |
Ammo (POWW) | 3/5/2017 - 3/25/2017 | 75% |
Viewbix Inc Common Stock (VBIX) | 3/5/2017 - 3/25/2017 | 69.23% |
Clean Energy Technologies, Inc Common Stock (CETY) | 3/5/2017 - 3/25/2017 | 65.15% |
Aurinia Pharmaceuticals (AUPH) | 3/5/2017 - 3/25/2017 | 60.4% |
Corvus Pharmaceuticals (CRVS) | 3/5/2017 - 3/25/2017 | 54.81% |
Nektar Therapeutics (NKTR) | 3/5/2017 - 3/25/2017 | 53.77% |
Datasea (DTSS) | 3/5/2017 - 3/25/2017 | 51.25% |
Filana Therapeutics (FLNA) | 3/5/2017 - 3/25/2017 | 48.28% |
Cassava Sciences (SAVA) | 3/5/2017 - 3/25/2017 | 48.28% |
Castellum (CTM) | 3/5/2017 - 3/25/2017 | 47.14% |
Catalyst Pharmaceuticals (CPRX) | 3/5/2017 - 3/25/2017 | 45.3% |
XOMA (XOMA) | 3/5/2017 - 3/25/2017 | 43.83% |
Verastem (VSTM) | 3/5/2017 - 3/25/2017 | 43.1% |
SurgePays (SURG) | 3/5/2017 - 3/25/2017 | 42.86% |
Xpel (XPEL) | 3/5/2017 - 3/25/2017 | 42.23% |
Beasley Broadcast (BBGI) | 3/5/2017 - 3/25/2017 | 41.38% |
CleanSpark (CLSK) | 3/5/2017 - 3/25/2017 | 40.85% |
Scienture (SCNX) | 3/5/2017 - 3/25/2017 | 40.03% |
HUTCHMED DRC (HCM) | 3/5/2017 - 3/25/2017 | 39.17% |
Eterna Therapeutics (ERNA) | 3/5/2017 - 3/25/2017 | 37.72% |
